Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M R, Parashchak"'
Publikováno v:
Respiratory medicine. 93(4)
Four hundred and sixty nine patients were randomized to receive either 12 micrograms bd of eformoterol (Oxis, Astra Pharmaceuticals Ltd., Kings Langley, U.K.) delivered via Turbohaler or 50 micrograms bd salmeterol (Serevent, Glaxo-Wellcome Ltd., Uxb